Federal drug defense (N.D. & E.D. Texas)

The Controlled Substances Act and Schedules I-V

The Controlled Substances Act (21 U.S.C. § 801 et seq.) governs every federal drug prosecution. Substances are classified into Schedules I through V under 21 U.S.C. § 812, with Schedule I (LSD, marijuana federally) carrying the most exposure and Schedule V the least. Distribution, manufacture, and possession with intent live at § 841(a)(1).

Schedule I

No accepted medical use and high potential for abuse —, LSD, MDMA, psilocybin, and (still, as a matter of federal law as of 2026) marijuana. Distribution of any Schedule I or II substance under 21 U.S.C. § 841(a)(1) is a felony with penalty bands set by § 841(b). The federal-state divergence on marijuana is the most consequential operational difference: conduct legal under Texas hemp law (under 0.3% THC) can still violate federal Schedule I where the testing methodology or the actual THC content disputes the categorization.

Schedule II

Accepted medical use with severe abuse potential — cocaine, methamphetamine, (and most analogues), Adderall, and most pharmaceuticals. Schedule II substances are the workhorse of federal drug prosecutions in N.D. and E.D. Texas because the DEA Dallas Field Division and the OCDETF task forces concentrate enforcement here. Cocaine, methamphetamine, and together drive the great majority of § 841 indictments returned in the DFW federal districts.

Schedules III, IV, V

Lower abuse potential and accepted medical use — testosterone and anabolic steroids (Schedule III), Xanax and other benzodiazepines (Schedule IV), and cough preparations with limited (Schedule V). Distribution still carries felony exposure but at lower mandatory-minimum thresholds; the § 841(b)(1)(C) "all other Schedule I/II" catch-all does not apply, and the more typical exposure under § 841(b)(1)(D)–(E) is a 5- or 10-year maximum without a statutory floor.

Substantive offense vs. conspiracy

Section 841(a)(1) covers the substantive offense — distribution, dispensation, or possession with intent to distribute. Section 846 makes it an offense to attempt or conspire to commit any § 841 offense, and it carries the same penalty range as the substantive offense. Conspiracy is the more common charge because the government can join multiple defendants, draw in co-conspirators' statements under Fed. R. Evid. 801(d)(2)(E), and use a single overt act anywhere to anchor venue. Whitfield v. United States, 543 U.S. 209 (2005), confirmed that the § 846 conspiracy does not require an overt act — agreement alone suffices.

Federal drug prosecutions in the Northern and Eastern Districts of Texas almost always charge § 841(a)(1) and § 846 conspiracy together. The conspiracy count carries the same mandatory minimums as the substantive offense (a 10-year floor at the (b)(1)(A) drug quantities, a 5-year floor at (b)(1)(B) quantities, no statutory floor at (b)(1)(C)) but the doctrinal tools are different. On the substantive count, the government must prove a specific distribution act; on the conspiracy count, agreement and knowledge of the conspiracy's objective suffice. The strategic implication for defense is significant: a defendant whose evidence connects only to a single uncharged sale may still face conspiracy liability for the full quantity attributable to the broader scheme under Pinkerton v. United States, 328 U.S. 640 (1946) — a doctrine often called the most punishing rule in federal drug law.

Substantive § 841 and conspiracy under § 846 — what the government must prove

Section 841(a)(1) requires proof of knowing or intentional manufacture, distribution, or possession with intent to distribute a controlled substance. Section 846 conspiracy adds an agreement element but does not require an overt act. Both counts share the § 841(b) penalty bands and the same Alleyne quantity-element rule.

The substantive § 841(a)(1) offense requires the government to prove three elements beyond a reasonable doubt: (1) knowing or intentional conduct, (2) a controlled substance, and (3) distribution, dispensation, or possession with intent to distribute. The knowing-or-intentional element is mens rea: the defendant must have known the substance was a controlled substance, though the government need not prove knowledge of the specific drug or its precise Schedule. McFadden v. United States, 576 U.S. 186 (2015), confirmed that the government must prove the defendant knew the substance was "controlled" or knew its identity — a distinction that becomes critical in synthetic cannabinoid, analog, and -laced-substance prosecutions.

The conspiracy charge under § 846 requires proof of an agreement between two or more persons to commit a § 841 offense and knowing participation in the agreement. Unlike most federal conspiracy statutes (18 U.S.C. § 371 and most others), § 846 does not require an overt act in furtherance — agreement alone, plus the defendant's knowing membership, is sufficient under Whitfield v. United States, 543 U.S. 209 (2005). The breadth of the conspiracy doctrine is the single largest exposure multiplier in federal drug law: a defendant who participated in a small portion of a larger scheme can be held responsible at sentencing for the entire quantity reasonably foreseeable to that defendant under the Pinkerton doctrine and USSG § 1B1.3 (relevant conduct).

Drug-quantity allegations are elements of the offense, not sentencing factors. Under Apprendi v. New Jersey, 530 U.S. 466 (2000), and its mandatory-minimum extension in Alleyne v. United States, 570 U.S. 99 (2013), any fact that increases the statutory minimum or maximum must be charged in the indictment and proved to a jury beyond a reasonable doubt (or admitted in a guilty plea). This means the government must allege specific quantities — "500 grams or more of cocaine," "5 kilograms or more of cocaine" — and the jury must find each threshold. Defense counsel should examine every indictment for whether the quantity allegation is anchored to a specific drug and a specific threshold, and whether the trial proof actually corresponds to what was charged. A guilty plea that does not include an explicit admission of the quantity threshold cannot trigger the mandatory minimum on Alleyne grounds.

Conspiracy proof routinely rests on co-conspirator statements under Federal Rule of Evidence 801(d)(2)(E). The government may admit a co-conspirator's out-of-court statements against the defendant if the statements were made during the course of and in furtherance of the conspiracy. Defense counsel litigates the foundational predicate — proof of a conspiracy by a preponderance of independent evidence under Bourjaily v. United States, 483 U.S. 171 (1987) — through motions in limine. A successful challenge keeps damaging statements out of evidence and frequently changes the trial calculus from "concede conspiracy, fight quantity" to "fight conspiracy first."

Drug quantity and mandatory minimums — the § 841(b) schedule

The mandatory-minimum schedule under 21 U.S.C. § 841(b) drives the entire federal drug case. The (b)(1)(A) "high-tier" quantities trigger 10-year floors; the (b)(1)(B) "mid-tier" quantities trigger 5-year floors; (b)(1)(C) lower quantities carry no statutory minimum but a 20-year maximum. Each tier doubles with a § 851 prior.

The (b)(1)(A) "high-tier" threshold under § 841(b)(1)(A) triggers a 10-year mandatory minimum and a maximum of life. For Penalty-Group-1 controlled substances most often charged in N.D. and E.D. Texas, the (b)(1)(A) quantities are: 1 kilogram or more of ; 5 kilograms or more of cocaine; 280 grams or more of crack cocaine (the Fair Sentencing Act of 2010 ratio); 50 grams or more of methamphetamine actual or 500 grams or more of methamphetamine mixture; 100 grams or more of PCP actual or 1 kilogram or more of mixture; 10 grams or more of LSD; 1,000 kilograms or more of marijuana or 1,000 plants; and 40 grams or more of pure or 400 grams or more of a mixture. Where the offense results in death or serious bodily injury, the 10-year minimum becomes a 20-year minimum; with a § 851 prior, the floor rises further and life becomes mandatory if both death and a prior are present.

The (b)(1)(B) "mid-tier" threshold triggers a 5-year mandatory minimum and a 40-year maximum. The (b)(1)(B) quantities are: 100 grams or more of ; 500 grams or more of cocaine; 28 grams or more of crack; 5 grams or more of methamphetamine actual or 50 grams or more of mixture; 10 grams or more of PCP actual or 100 grams or more of mixture; 1 gram or more of LSD; 100 kilograms or more of marijuana or 100 plants; and 4 grams or more of pure or 40 grams or more of mixture. Death or serious bodily injury raises the floor to 20 years; a § 851 prior raises the floor further. The (b)(1)(C) catch-all for "any other amount" of a Schedule I or II controlled substance carries no statutory minimum but a 20-year maximum (30 years with death/SBI; further enhanced with a § 851 prior).

The actual-vs-mixture distinction in the meth and thresholds is decisive in many cases. The (b)(1)(A) high-tier for methamphetamine is reached at 50 grams of "actual" (pure) methamphetamine — but at 500 grams of any mixture or substance containing a detectable amount. A 50-gram seizure that is 95% pure crosses the actual threshold and carries the 10-year minimum; a 500-gram seizure of "ice" that is only 25% pure (125 grams actual) crosses the mixture threshold at the same 10-year exposure. DEA lab purity testing is the most consequential single piece of evidence in any methamphetamine prosecution, and counsel routinely retains independent chemists to retest where the seizure quantity sits near a threshold. follows a similar logic, with the pure-vs-mixture ratio (10× difference) and the substantially smaller seizure quantities pushing many prosecutions into the high-tier range on relatively small physical seizures.

Quantity findings are exposed to challenge on three doctrinal fronts. First, under Alleyne, the threshold quantity must be charged in the indictment and found by the jury beyond a reasonable doubt — not merely included in the presentence report and adopted by the court. Second, under USSG § 1B1.3 (relevant conduct), the sentencing quantity may include uncharged acts in the same scheme — defense counsel litigates the scope of the conspiracy to limit attributable quantity. Third, the lab analysis itself is subject to challenge: protocols, instrument calibration, analyst certifications, chain of custody, and (especially in -mixture cases) the homogeneity of the seized substance can all be litigated through Daubert motions and independent retesting.

A separate consecutive mandatory minimum of 5 years (7 years if brandished, 10 years if discharged, 25 years for a second or subsequent conviction) applies under 18 U.S.C. § 924(c) for possessing a firearm in furtherance of a drug-trafficking crime. The 924(c) sentence is stacked on top of any § 841 sentence and cannot be reduced by the safety valve. Dean v. United States, 581 U.S. 62 (2017), authorized district courts to consider the 924(c) consecutive sentence when calculating the predicate drug sentence — a useful but narrow form of relief. Defense counsel attacks the "in furtherance of" element aggressively: a firearm at the same residence as drugs is not automatically "in furtherance of" trafficking, and the case-law standard requires a specific nexus between the gun and the drug activity.

§ 851 prior-offense notices after the First Step Act

A timely-filed § 851 information based on a qualifying prior dramatically raises mandatory minimums — but the First Step Act of 2018 narrowed which priors qualify, and the categorical approach under Mathis often defeats the enhancement even where a notice was filed.

The § 851 notice procedure is a statutory predicate the government must satisfy before any prior drug felony can enhance a mandatory minimum. Under 21 U.S.C. § 851(a)(1), the United States must file an "information" — a written notice — with the court and serve the defendant before trial (or before the entry of a guilty plea). The notice must state the prior conviction the government will rely on. A § 851 information filed after trial begins or after a plea is entered is untimely as a matter of law and cannot support the enhancement. Perez-Olalde v. United States, 600 F.3d 295 (3d Cir. 2010), and analogous Fifth Circuit decisions including United States v. Bell, 966 F.3d 391 (5th Cir. 2020), have rejected late or defective § 851 informations and reversed enhanced sentences.

The First Step Act of 2018 (Pub. L. 115-391, § 401) narrowed the predicate for § 851 enhancement from "felony drug offense" to "serious drug felony." A "serious drug felony" is defined at 21 U.S.C. § 802(57) as an offense described in 18 U.S.C. § 924(e)(2) (ACCA-style predicate) for which the defendant served a term of imprisonment of more than 12 months and for which the defendant's release from any term of imprisonment was within 15 years of the instant offense. The 12-months-actually-served and 15-year-release-window requirements are objective and contestable: many priors that previously triggered § 851 doubling no longer qualify under the narrower FSA definition. The First Step Act applies prospectively to sentencings imposed after December 21, 2018, and is the single most consequential change in federal drug sentencing in a generation.

The categorical approach under Mathis v. United States, 579 U.S. 500 (2016), governs whether a state-court drug conviction qualifies as a federal § 851 predicate. The court compares the elements of the state offense to the federal "controlled substance" definition: if the state statute criminalizes more conduct than the federal definition reaches — for example, a state statute that includes substances no longer (or never) on the federal schedules — the prior is categorically overbroad and cannot qualify. Borden v. United States, 593 U.S. 420 (2021), narrowed the categorical-approach analysis on mens rea grounds. Texas state-court drug priors, especially older ones predating updates to the federal schedules, are routinely defeated on Mathis/Borden categorical-approach grounds.

Defense response to a § 851 notice runs on a short timeline. Under § 851(c), the defendant must file a written response affirming or denying the alleged prior before sentencing. A failure to respond can waive the right to challenge the prior. Counsel files a written denial within the schedule fixed by the trial court, then litigates the prior on categorical-approach grounds, statutory-definition grounds (does the prior meet the FSA "serious drug felony" definition?), and constitutional grounds (Sixth Amendment challenges under Apprendi/Alleyne remain available but narrow). Where the § 851 enhancement is successfully defeated, the mandatory-minimum exposure drops back to the unenhanced level — frequently a 5- or 10-year reduction in the floor.

Defenses we evaluate first

Federal drug defense engages five core doctrines: drug-quantity element attacks under Alleyne, knowledge-of-substance challenges under McFadden, conspiracy-scope challenges, Fourth Amendment suppression under federal standards (no Article 38.23), and 851/safety-valve sentencing strategy.

The single highest-leverage move in any federal drug case is a quantity-element challenge under Alleyne v. United States, 570 U.S. 99 (2013). The government must charge specific drug quantity thresholds in the indictment — "500 grams or more of cocaine," "5 kilograms or more of cocaine" — and the jury must find each threshold beyond a reasonable doubt. Defense counsel examines the indictment for whether the quantity allegation is anchored to a specific drug and a specific § 841(b) tier. At trial, counsel litigates the lab analysis: protocol compliance with DEA testing standards, instrument calibration logs, analyst certifications, chain-of-custody completeness, and (in mixture cases) homogeneity testing. A successful quantity-element defense can drop the case from a (b)(1)(A) 10-year floor to a (b)(1)(B) 5-year floor, or from (b)(1)(B) to (b)(1)(C) with no mandatory minimum at all — and can defeat the offense level under USSG § 2D1.1 at sentencing.

Knowledge-of-substance challenges under McFadden v. United States, 576 U.S. 186 (2015), apply most powerfully to analog, synthetic, and -laced cases. The government must prove the defendant knew the substance was a controlled substance or knew its specific identity. In analog cases — substances designed to be chemically similar to scheduled drugs — the government often cannot prove the defendant knew the specific compound was controlled. In -laced cases, where the seizure is nominally or cocaine but lab analysis reveals content, the defendant may not have known was present, which can defeat the -quantity enhancement even where the underlying distribution is conceded. Burrage v. United States, 571 U.S. 204 (2014), applies a "but-for" causation standard to the death-resulting enhancement — meaning multiple-substance toxicology in a fatal overdose case often defeats the enhancement entirely.

Conspiracy-scope challenges under Whitfield and the line of "multiple conspiracies" cases (Kotteakos v. United States, 328 U.S. 750 (1946), and progeny) limit the quantity attributable to a peripheral defendant. The government often charges a broad single conspiracy and seeks to attribute the entire conspiracy's quantity to every member at sentencing under Pinkerton and USSG § 1B1.3. Defense counsel argues that the evidence shows multiple smaller conspiracies — the defendant participated in one but not the others — or that the defendant's knowledge and agreement extended only to a portion of the larger scheme. Where successful, the attributable quantity drops to what the defendant personally distributed plus what was reasonably foreseeable to that defendant, often a fraction of the indictment's alleged total.

Fourth Amendment suppression in federal drug cases runs differently from Texas state practice. There is no Article 38.23 — the federal exclusionary rule includes a good-faith exception under United States v. Leon, 468 U.S. 897 (1984), making warrant challenges narrower. But the federal rule on stop-prolongation under Rodriguez v. United States, 575 U.S. 348 (2015), applies fully: an officer cannot extend a traffic stop, even briefly, to conduct a dog sniff without independent reasonable suspicion. Federal cases also frequently involve Title III wiretap challenges (18 U.S.C. § 2518 — necessity, minimization, and disclosure-deadline requirements), GPS tracker challenges (United States v. Jones, 565 U.S. 400 (2012)), Network Investigative Technique (NIT) challenges in dark-web prosecutions, and grand-jury subpoena challenges for cellphone and account data. The federal suppression docket is technically demanding but produces meaningful results — Rodriguez prolongation challenges in particular have produced a steady stream of suppression wins in TXND and TXED.

Safety-valve eligibility under 18 U.S.C. § 3553(f) is the single most important sentencing tool in federal drug practice and is evaluated from day one. The five eligibility prongs are: (1) the defendant has no more than 4 criminal history points under USSG (as expanded by the First Step Act from the prior 1-point limit); (2) the defendant did not use violence or possess a firearm in connection with the offense; (3) the offense did not result in death or serious bodily injury; (4) the defendant was not an organizer, leader, manager, or supervisor and not engaged in a continuing criminal enterprise; and (5) the defendant truthfully and completely disclosed all information about the offense to the government before sentencing. Pulsifer v. United States, 601 U.S. 124 (2024), clarified the criminal-history calculation methodology under prong (1), holding that the three sub-conditions must each be satisfied (not satisfied in the alternative). Counsel structures the case from indictment forward to preserve safety-valve eligibility — especially the disclosure prong, which requires the defendant to debrief truthfully and completely before sentencing.

Common prosecution errors in federal drug cases

The government's typical errors in federal drug cases are predictable: DEA-lab quantity rounding, over-broad conspiracy charging, defective or untimely § 851 notices, pure-vs-mixture confusion, Burrage but-for causation overlooked, Rodriguez stop-prolongation, and § 924(c) "in furtherance" treated as automatic.

A consistent pattern emerges across N.D. and E.D. Texas drug dockets. First, DEA-lab quantity rounding and reporting errors. The DEA Mid-Atlantic Laboratory (and the South Central Laboratory in Dallas) report quantities to specified decimal precision. Where the seizure sits near a § 841(b) threshold — for example, a meth seizure reported as 49.7 grams of "actual" methamphetamine, just below the 50-gram (b)(1)(A) threshold — defense counsel scrutinizes the lab's rounding methodology and frequently obtains independent retesting. Where the government charged the (b)(1)(A) tier and the lab quantity sits below the threshold on independent retest, the mandatory minimum drops by 5 years.

Second, over-broad conspiracy charging. The government routinely charges a single global conspiracy encompassing every defendant whose conduct touched the alleged scheme, then seeks Pinkerton-style attribution of the entire conspiracy quantity to every defendant at sentencing. Defense counsel litigates the multiple-conspiracies issue at trial (through a Kotteakos instruction) and at sentencing (through objections to the presentence report under Fed. R. Crim. P. 32). Where the evidence shows the defendant participated in only one of several distinct schemes, or knew only a portion of the larger conspiracy, the attributable quantity at sentencing can be dramatically reduced.

Third, defective or untimely § 851 notices. The statutory requirement is rigid: the information must be filed and served before trial begins or before the guilty plea. Notices filed after voir dire begins, after the defendant has entered a plea, or with defective service have all been rejected on appeal. The Fifth Circuit has consistently enforced the § 851(a) timing requirement strictly, and TXND/TXED cases periodically present timing defects that defense counsel raises in post-trial briefing.

Fourth, pure-vs-mixture confusion in § 841(b) thresholds. The (b)(1)(A) thresholds for methamphetamine and are stated in both "actual" (pure) and "mixture" forms — but the government sometimes treats the more favorable threshold as automatic. Defense counsel ensures the indictment and trial proof tracks the specific § 841(b) sub-paragraph alleged, and litigates the conversion from mixture-weight to actual-weight (using lab purity numbers) where the conversion would drop the case to a lower tier.

Fifth, Burrage but-for causation overlooked in death-resulting enhancements. The 20-year minimum (or life with a § 851 prior) for offenses resulting in death applies only where the distributed substance is a but-for cause of the death. Burrage v. United States, 571 U.S. 204 (2014), is unambiguous: contributory or "substantial factor" causation is insufficient. In -overdose prosecutions, the decedent's toxicology frequently shows multiple substances, and the medical examiner's cause-of-death opinion may not satisfy the Burrage standard. Defense counsel retains independent medical examiners and challenges the government's causation theory under Burrage — successful challenges defeat the death-resulting enhancement entirely.

Sixth, Rodriguez stop-prolongation challenges underused. The government's response to a Rodriguez challenge often relies on bare officer-narrative recitations of "reasonable suspicion" — visible nervousness, contradictory travel stories, food wrappers in the vehicle. Defense counsel demands dash-cam and body-cam timestamps and traces the exact second the traffic mission was complete (license/registration handed back; warning or citation written). Where the dog sniff occurred after that point and the officer cannot articulate fresh reasonable suspicion, suppression follows. The federal good-faith exception does not save a Rodriguez violation because the violation is the officer's own conduct, not reliance on a defective warrant.

Seventh, § 924(c) "in furtherance" treated as automatic. The government often charges a § 924(c) firearm count on the bare fact that a firearm was found near drugs. The "in furtherance" element requires a specific nexus — the firearm advanced, protected, or otherwise furthered the drug-trafficking activity. United States v. Ceballos-Torres, 218 F.3d 409 (5th Cir. 2000), and progeny require analysis of factors including the type of weapon, whether it was loaded, its proximity to the drugs, its accessibility, the type of drug activity, and the surrounding circumstances. A handgun in a bedside drawer in a home where small quantities of drugs were also found may not satisfy the standard; an assault rifle next to a kilogram of cocaine in an active stash house likely will. The "in furtherance" question is jury-submissible and defense counsel litigates it through specific jury instructions and Rule 29 motions.

What to do if you're facing a federal drug indictment in N.D. or E.D. Texas

The pre-indictment window is the highest-leverage period in any federal drug case. After indictment, the first 30 days are decisive for cooperation decisions, detention-hearing posture, and discovery strategy. Pre-charge engagement of federal counsel changes outcomes in measurable ways.

The first signal of a federal drug investigation is often a target letter from the United States Attorney, a grand-jury subpoena to a third party (cellphone carrier, bank, social-media account), or — in the cases that escalate fastest — an arrest pursuant to a sealed indictment. In the target-letter window, defense counsel can sometimes obtain a pre-indictment meeting with the AUSA, present mitigating information, advocate for declination or referral to state prosecution, or negotiate the structure of a future plea before charges are filed. Pre-indictment cooperation, where appropriate, is often substantially more valuable than post-indictment cooperation because it can change the charges filed (and therefore the mandatory-minimum exposure) rather than merely affecting the sentence on charges already brought.

Detention hearings under 18 U.S.C. § 3142 are decisive. Most § 841(b)(1)(A) and (b)(1)(B) drug indictments are subject to a rebuttable presumption of detention under § 3142(e)(3)(A) — the defendant must rebut both flight risk and danger to the community to obtain release. Defense counsel prepares for the detention hearing immediately, gathering documentary evidence of community ties, employment, family responsibilities, mental health and substance-use treatment options, and third-party custodian arrangements. The Sherman and Plano divisions of E.D. Texas, the Dallas and Fort Worth divisions of N.D. Texas, and the Sherman division of N.D. Texas each have somewhat different magistrate practices on detention — counsel's familiarity with the assigned magistrate is significant.

Do not give a post-arrest statement without counsel. Federal drug investigations live on the defendant's own statements. The FBI, DEA, and HSI agents who conduct post-arrest interviews are skilled at developing admissions in casual-seeming conversations. Recorded jail-cell calls are routinely admitted at trial under Fed. R. Evid. 801(d)(2)(A). Statements to cellmates can become cooperator testimony. The Fifth Amendment privilege protects only silence — invoke counsel explicitly ("I want a lawyer; I will not answer questions") and maintain silence thereafter. Family-call admissions in the first 24 hours after arrest have lost more federal drug cases than any single defense error.

The cooperation decision is on the clock from day one. The government extends cooperation opportunities most generously in the immediate post-arrest window — pre-charge or in the first few weeks after indictment — and the incremental value of cooperation declines as the case progresses. 5K1.1 motion filings by the government are entirely within prosecutorial discretion, and a defendant cannot file or compel one. Cooperation under 18 U.S.C. § 3553(e) is the only mechanism (other than the safety valve) that authorizes a sentence below a mandatory minimum. Cooperation carries significant risks: retaliation, immigration consequences, family safety, federal-state coordination problems, and the requirement to testify if called. Counsel evaluates the cooperation opportunity with the client in a structured way — never as a default, always with full disclosure of risks and benefits.

Preserve every digital trace. Federal drug prosecutions increasingly rely on encrypted-messaging metadata, payment-app records (Cash App, Venmo, Zelle), cloud-storage data, and cellphone geolocation. Defense counsel sends preservation letters to every platform identified in the discovery within the first weeks of representation, and litigates the government's use of the same data under the Fourth Amendment and Fifth Circuit case law on cellphone searches (Carpenter v. United States, 585 U.S. 296 (2018)). Where the government obtained data through grand-jury subpoena rather than warrant, the defense's parallel access becomes a discovery dispute under Fed. R. Crim. P. 16 and Brady v. Maryland, 373 U.S. 83 (1963).

DFW-specific context (N.D. Texas, E.D. Texas, BOP, and cost)

N.D. Texas (Dallas, Fort Worth, Plano, Sherman, Amarillo, Lubbock, San Angelo, Wichita Falls, Abilene) and E.D. Texas (Sherman, Plano, Marshall, Tyler, Beaumont, Lufkin, Texarkana) handle every federal drug indictment in DFW. The DEA Dallas Field Division, OCDETF, and HSI joint task forces drive most prosecutions.

The Northern District of Texas covers the Dallas, Fort Worth, Plano, Sherman, and other divisions. Federal drug prosecutions for Frisco, Plano, McKinney, and the Collin County area generally proceed in the Plano or Sherman division of N.D. Texas. Federal prosecutions for Dallas, Garland, Irving, and the Dallas County area proceed in the Dallas division. Federal prosecutions for Fort Worth, Arlington, and the Tarrant County area proceed in the Fort Worth division. Each division has its own assigned U.S. District Judges and U.S. Magistrate Judges — judge assignment can significantly affect the case's trajectory, particularly on Guidelines departures and detention rulings.

The Eastern District of Texas covers the Sherman, Plano, Marshall, Tyler, Beaumont, and Lufkin divisions. Plano and Sherman divisions of E.D. Texas geographically overlap with the Plano and Sherman divisions of N.D. Texas, creating jurisdictional choices that sometimes drive forum-selection negotiation. The Sherman division of E.D. Texas covers parts of Grayson, Fannin, and Collin counties. The Plano division of E.D. Texas covers parts of Collin, Denton, and surrounding areas. Federal drug cases involving conduct that crossed county or district lines may be subject to venue motions under Fed. R. Crim. P. 18, with the choice of venue affecting judge assignment, jury pool, and the AUSA team handling the case.

The DEA Dallas Field Division drives most federal drug enforcement in the DFW region. The Field Division operates investigative groups focused on, methamphetamine, cocaine and with substantial focus in recent years on Mexican-cartel-linked supply chains entering the DFW market. The Organized Crime Drug Enforcement Task Force (OCDETF) coordinates multi-agency investigations and runs large-scale conspiracy cases that often produce 20+ defendant indictments. HSI joint operations with DEA frequently appear in cases involving border-crossing import allegations under 21 U.S.C. § 952 (importation), which carries the same penalty structure as § 841 but with separate venue and proof considerations. The N.D. Texas U.S. Attorney's Office maintains a Narcotics and Money Laundering Section that prosecutes most § 841 and § 846 cases; the E.D. Texas U.S. Attorney's Office runs a parallel section out of Plano and Tyler.

Federal sentences are served in Bureau of Prisons facilities. The BOP system includes several Texas facilities relevant to N.D./E.D. Texas defendants: FCI Seagoville (low and medium security, southeast of Dallas — frequently designated for DFW-area defendants); FCI Texarkana (low and medium); FCI Three Rivers (medium); FCI La Tuna (low, near El Paso); USP Pollock and Beaumont (high security); and a range of medical and administrative facilities. Designation requests under 18 U.S.C. § 3621(b) can identify a preferred facility — and counsel routinely includes BOP-designation advocacy in the sentencing-mitigation package. Federal good-time credit is approximately 54 days per year served (about 15%), and First Step Act earned-time credits can further reduce the time served through programming participation.

Federal drug defense in N.D./E.D. Texas runs $25,000–$75,000 in attorney fees for a typical single-defendant prosecution through trial, with significant variation based on complexity, expert needs, and forum. A pre-indictment representation that resolves with declination or charges-filed-in-state-court may run substantially less ($10,000–$25,000). A multi-defendant conspiracy case with wiretap suppression issues, multiple experts, and a likely trial may run $100,000–$250,000+. Expert costs (independent chemists for purity and quantity testing $5,000–$15,000; mitigation specialists for sentencing $5,000–$15,000; investigators $5,000–$25,000) add materially. The Federal Public Defender for N.D. Texas and the CJA Panel for both districts provide indigent representation for defendants who qualify — and the quality of federal defender work in TXND and TXED is high. The 5K1.1 cooperation timeline runs 1–3 years from indictment to sentencing post-cooperation, during which the defendant typically remains under bond conditions or, less commonly, in detention. Federal forfeiture under 18 U.S.C. § 982 and 21 U.S.C. § 853 runs in parallel — vehicles, currency, real property, and electronics linked to the offense face seizure on a different timeline from the criminal case itself, and the forfeiture defense often requires separate fee allocation.